Docoh
Loading...

LXRX Lexicon Pharmaceuticals

Employees

Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM



Our annual meeting of stockholders was held on April 29, 2021 to consider and vote on the following proposals. The voting results with respect to each matter are set forth below:







(1)Election of Class III Directors
Name of DirectorForWithheldBroker

Non-Votes
Philippe J. Amouyal104,066,2899,551,12111,677,330
Lonnel Coats113,017,046600,36411,677,330
Frank P. Palantoni108,872,1134,745,29711,677,330


ForAgainstWithheldBroker

Non-Votes
(2)Ratification and approval of the Company's Second Amended and Restated Certificate of Incorporation92,542,67220,518,676556,06211,677,330
ForAgainstWithheldBroker

Non-Votes
(3)Ratification and approval of the amendment to the Company's 2017 Non-Employee Directors’ Equity Incentive Plan111,261,1302,288,48367,79711,677,330
ForAgainstWithheldBroker

Non-Votes
(4)Advisory vote to approve the compensation paid to the Company's named executive officers94,641,71718,373,001602,69211,677,330
ForAgainstWithheldBroker

Non-Votes
(5)Ratification and approval of the appointment of Ernst & Young LLP as Company's independent auditors for the fiscal year ending December 31, 2021125,012,456116,013166,271